Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe date on the webpage has been updated from March 20, 2025, to April 17, 2025.SummaryDifference0.7%
- Check12 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check20 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.7%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe date has been updated from February 19, 2025, to March 20, 2025.SummaryDifference0.7%
- Check63 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a new date has been added.SummaryDifference6%
- Check77 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.